Immunogenicity 14962
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
PCYT2
Transcript ID
uc031rex.1
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (335 aa)
MIRNG
1
RGAAG
6
GAEQP
11
GPGGR
16
RAVRV
21
WCDGC
26
YDMVH
31
YGHSN
36
QLRQA
41
RAMGD
46
YLIVG
51
VHTDD
56
DITLT
61
VDGRD
66
TYEEV
71
KQAGR
76
YRECK
81
RTQGV
86
STTDL
91
VGRML
96
LVTKA
101
HHSSQ
106
EMSSE
111
YREYA
116
DSFGK
121
CPGGR
126
NPWTG
131
VSQFL
136
QTSQK
141
IIQFA
146
SGKEP
151
QPGET
156
VIYVA
161
GAFDL
166
FHIGH
171
VDFLE
176
KVHRL
181
AERPY
186
IIAGL
191
HFDQE
196
VNHYK
201
GKNYP
206
IMNLH
211
ERTLS
216
VLACR
221
YVSEV
226
VIGAP
231
YAVTA
236
ELLSH
241
FKVDL
246
VCHGK
251
TEIIP
256
DRDGS
261
DPYQE
266
PKRRG
271
IFRQI
276
DSGSN
281
LTTDL
286
IVQRI
291
ITNRL
296
EYEAR
301
NQKKE
306
AKELA
311
FLEAA
316
RQQAA
321
QPLGE
326
RDGDF
331
Mutation Information
DNA mutation:
None
Peptide Range:
255 ~ 279
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"KTEIIPDRDGSDPYQEPKRRGIFRQ
||||||||||||.||||||||||||
Mutant:
KTEIIPDRDGSDLYQEPKRRGIFRQ"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) PCYT2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay